The impact of hepatitis C burden: an evidence-based approach-Reference-Cited by-同舟云学术

The impact of hepatitis C burden: an evidence-based approach

Published:2014-01-26 Issue:5 Volume:39 Page:518-531
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Younossi Z. M.¹²,Kanwal F.³,Saab S.⁴,Brown K. A.⁵,El-Serag H. B.³,Kim W. R.⁶,Ahmed A.⁷,Kugelmas M.⁸,Gordon S. C.⁵

Affiliation:

1. Betty and Guy Beatty Center for Integrated Research; Inova Health System; Falls Church VA USA

2. Department of Medicine; Center for Liver Disease; Inova Fairfax Hospital; Falls Church VA USA

3. Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine Houston; Houston TX USA

4. Department of Medicine; Geffen School of Medicine; University of California; Los Angeles CA USA

5. Division of Gastroenterology; K-7 Gastro; Henry Ford Hospital; Detroit MI USA

6. Mayo Clinic; Rochester MN USA

7. Division of Gastroenterology and Hepatology; Stanford University School of Medicine; Liver Transplant Program; Stanford University Medical Center; Stanford CA USA

8. Divisions of Gastroenterology and Hepatology; University of Colorado; Denver CO USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12625/fullpdf

Reference109 articles.

1. The Institute of Medicine report on viral hepatitis: a call to action;Sanyal;Hepatology,2010

2. Liver and intestine transplantation in the United States, 1997-2006;Freeman;Am J Transplant,2008

3. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis;Velázquez;Hepatology,2003

4. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma;Yang;Clin Gastroenterol Hepatol,2011

5. Natural history of acute and chronic hepatitis C;Maasoumy;Best Pract Res Clin Gastroenterol,2012

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes;World Journal of Hepatology;2024-08-27

2. Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California;The American Journal of Managed Care;2023-10-20

3. The effect of hepatitis C—associated premature deaths on labour productivity losses in Spain: a ten-year analysis;The European Journal of Health Economics;2022-11-10

4. Does Hepatitis C Independently Increase the Risk of Colorectal Adenoma?;EMJ Oncology;2022-10-25

5. Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective;Journal of Managed Care & Specialty Pharmacy;2022-10